Pharmacy leadership during emergency preparedness: Insights from the Middle East and South Asia

Siddiqui, Mohammad Aslam; Abdeldayem, Ahmed; Dayem, Khalid Abdel; Mahomed, Shuaib Haroon; Diab, Mariam Jihad

doi:10.1093/ajhp/zxaa133

Cited by 8 publications

(12 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to a recently published report addressing pharmacy leadership preparedness during emergency in the Middle East and South Africa, many clinical activities of pharmacists have continued and been performed through virtual tools and phone calls to maintain physical distancing, including medication reconciliation, bed-side discharge counseling, clinical rounds, anticoagulation, and heart failure clinics. 7 …”

Section: Introductionmentioning

confidence: 99%

Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital

Al-Quteimat

Siddiqui

Hussein

et al. 2022

Journal of Pharmacy Practice

View full text Add to dashboard Cite

Background: Pharmacists are integral members of the multidisciplinary healthcare team who, with their skills, knowledge, and training, are well positioned to prevent, identify, and manage medication-related issues. Many published articles related to COVID-19 management have highlighted the important role of the pharmacists in assuring the safe, effective, and cost-effective use of medications. During such challenging times of COVID-19 pandemic that resulted in a high demand on medical resources and healthcare providers, pharmacists are well positioned to contribute and add more efforts to the healthcare system to achieve best use of the available resources including medications and providing high quality pharmaceutical care to help the patients and support the healthcare providers. Methods: This is a retrospective chart review included all admitted adult patients with confirmed COVID-19 diagnosis from 1 March 2020 till 30 June 2020. The documented clinical pharmacist interventions were extracted from the EMR and reviewed by multiple clinical pharmacists to identify type, number, frequency, outcome, and physician’s acceptance rate of documented interventions. Results: A total of 484 pharmacist interventions included in the final analysis. Antimicrobial stewardship interventions were the most reported (149, 30.8%) and antibiotics were the most reported class of medication, constituting 31.1% of the total interventions. “Optimized therapy” was the most commonly reported outcome (58.8%). Overall, 50.8% (246) of the interventions were rated as having “moderate” clinical significance using the clinical significance scoring tool. The physicians’ acceptance rate was 94.7%. Conclusion: Pharmacist interventions are associated with improved communication and medication use in admitted adult patients with COVID-19. Clinical pharmacists can play a crucial role in optimizing medication use in patients with COVID-19 through prevention, identification, and resolving existing or potential drug-related problems.

show abstract

Section: Introductionmentioning

confidence: 99%

Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital

Al-Quteimat

Siddiqui

Hussein

et al. 2022

Journal of Pharmacy Practice

View full text Add to dashboard Cite

show abstract

“…Although pharmacists have been shown to share the most up-to-date evidence-based information from international sources such as the World Health Organization (WHO), the US Pharmacists Association, and the US Occupational Safety and Health Administration, and prevent crucial medication misuse or accidental loss. [20][21][22][23][24][25] Indeed, pharmacists have increased their knowledge of drugs and their side effects. At the same time, society chose pharmacists as the first direct source of up-to-date, trustworthy, and unbiased information.…”

Section: Conclusion/discussionmentioning

confidence: 99%

Current views of community and hospital pharmacists on pharmaceutical care services in the United Arab Emirates: A mixed methodological study

Kharaba

Farhat²,

Mahboub³

et al. 2022

F1000Res

155

View full text Add to dashboard Cite

Background: The profession of pharmacy has evolved significantly in recent years in terms of professional service delivery. The aim of this study was to explore the current views of pharmacists in the United Arab Emirates (UAE) on pharmaceutical care services and the nature of barriers encountered in practice using qualitative and quantitative assessment methods. Methods: A cross-sectional study was conducted among hospital and community pharmacists (n = 305) between March and May 2021, using qualitative and quantitative assessment methods. In the qualitative phase, 15 interviews were conducted to explore five main criteria: patient information, inadequate patient counseling, prescribing errors prevention and identifying drug-related problems, lack of participation in health awareness programs, and barriers to pharmaceutical care implementation. In the quantitative phase, 305 consenting pharmacists completed a questionnaire on seven criteria: demographic profile, pharmacist-physician interaction, patient counseling assessment, patient reports of adverse drug events, pharmacist participation in health awareness programs, perceptions of reducing prescribing errors and identifying drug-related problems, and barriers to appropriate pharmaceutical care implementation. Results: The results of both the qualitative and quantitative phases of the study revealed that pharmacists' influence on practice in the UAE is limited due to many factors, mainly lack of time and patients' ignorance of the pharmacist's role in the medical field. The mean responses regarding pharmacists' approach to patient counseling and patients' knowledge of pharmacists' role in managing adverse drug reactions were 77.1% and 59.7%, respectively. Active participation in health awareness programs was 64.8%. The mean positive response of participants in reducing prescribing errors and recognizing drug-related problems was 9.2%. Pharmacists' age and number of years in practice were the most important factors influencing the pharmaceutical care services implementation. Conclusion: The study has shown the need to shed light on the proper implementation of pharmaceutical care while maintaining a trusting relationship with physicians.

show abstract

“…Personal fears regarding contamination risk originating in nursing homes or between colleagues was an issue in some HPs and should be considered in any future pandemic preparedness plans. Regarding psychological support for their teams, pharmacy heads should listen to staff's concerns and take proactive steps to identify and offer help and guidance to those at risk of burnout or experiencing psychological distress (16). To this end, 40% of HPs introduced team briefings and debriefings, and hierarchies calmed and reassured their staff.…”

Section: Discussionmentioning

confidence: 99%

“…In some countries (14), HPs reorganised their activities to limit their HR risks: roles were redistributed and non-pharmacist staff were used to assist in manufacturing units and answer the phone (15). Another study reported HPs encouraging work from home and physical distancing (16). Our survey found that 47% (n=20) of HPs moved at-risk employees to safer environments.…”

Section: Discussionmentioning

confidence: 99%

Management of the Covid-19 Health Crisis: A Survey in Swiss Hospital Pharmacies

Schumacher

Dhif

Bonnabry

et al. 2020

Preprint

View full text Add to dashboard Cite

ObjectiveThis survey aims at reviewing the actions undertaken by Switzerland’s hospital pharmacies during the first wave of COVID-19 pandemic.MethodsA questionnaire covering topics related to the management of the COVID-19 crisis was sent to 65 heads of swiss hospital pharmacy.Results59% of pharmacies reported changes in the role of their staff. 41% of pharmacies had existing standard operating procedures or pandemic plans. 51% created new drug lists for: COVID-19-specific treatments (83% of pharmacies), sedatives (81%), anaesthetics (77%) and antibiotics (73%). Drug availability in COVID-19 wards was managed by increasing existing stocks (54% of pharmacies) and creating extra storage space (51%). Two drugs generated the most concern about shortages: propofol (49% of pharmacies) and midazolam (44%). Remdesivir stocks even ran out in 26% of pharmacies. 77% of pharmacies experienced problems procuring hand sanitiser solutions and 53% manufactured these themselves. Specific new documents were drafted to respond to medical needs with regards to drug administration (29% of pharmacies), drug preparation (29%) and treatment choices (24%). 47% of pharmacies implemented internal specific hygiene measures and 28% introduced team debriefings.ConclusionsSwiss hospital pharmacies encountered many challenges related to the COVID-19 crisis and had to find solutions quickly and effectively.

show abstract

Pharmacy leadership during emergency preparedness: Insights from the Middle East and South Asia

Cited by 8 publications

References 7 publications

Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital

Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital

Current views of community and hospital pharmacists on pharmaceutical care services in the United Arab Emirates: A mixed methodological study

Management of the Covid-19 Health Crisis: A Survey in Swiss Hospital Pharmacies

Contact Info

Product

Resources

About